Israel´s RCK signs Top Deal with Dutch Marihauna giant
The deal seals a cooperation with Dutch SeedTech.

Recently, RCK, an Israeli cannabis startup, signed a multi-million dollar deal with SeedTech from Holland, a pioneer in European cannabis. The seeds developed by RCK, a company specializing in science-based cannabis genetics, are designed to help create global mass production of medical cannabis. The agreement between RCK and SeedTech, a Dutch seed company, aims to develop unique cannabis strains in the form of elite hybrid seeds. RCK's operations are located in Kibbutz Ruhama, in southern Israel. The company operates a state-of-the-art laboratory, indoor grow rooms as well as a 1,500 square meter greenhouse and commercial propagation facility. As part of the agreement, RCK has developed a special breeding plan for SeedTech to develop unique cannabis strains for medical and commercial use. In addition to the initial payment for breeding services, RCK will also receive royalties from the sale of seeds for the duration of the patent term of each variety. "The agreement with SeedTech is the by-product of the pioneering science and technology mindset that we have developed and that is now developing its commercial potential," commented Dr. Noam Chehanovsky, Co-Founder and VP of Research and Development at RCK. "Over the past few years we've done a lot of research into cracking the genetic makeup of the cannabis plant and we have learned to control its chemical compounds. This makes it possible to quickly and efficiently breed new strains that precisely meet a variety of medical or commercial needs are suitable and enable the large-scale cultivation of high-quality cannabis plants that meet medical standards. "




